Skincare Formulation Using Neolignans and Ectoin for Anti-Aging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Skin aging is characterized by visible signs such as lines, wrinkles, loss of elasticity, and inflammation, which existing skincare formulations fail to adequately address, leading to cosmetic and health concerns.
Innovation Solution
A composition comprising neolignans, ergothioneine, and ectoin, potentially combined with magnolia bark extract, peptides, and ultraviolet spectrum attenuating agents, is applied topically to reduce skin aging symptoms by targeting inflammation, hydration, and cell protection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing skincare formulations are used, then basic skin care needs are met, but visible signs of skin aging (lines, wrinkles, loss of elasticity) are not adequately addressed
Solution Approach 1:
The patent combines multiple active ingredients (neolignans from magnolia bark, ergothioneine, and ectoin) into a composite skincare formulation. Each ingredient contributes different protective mechanisms: neolignans provide antioxidant and anti-inflammatory effects, ergothioneine offers cellular protection and DNA repair, and ectoin provides hydration and stress protection. This composite approach addresses multiple aspects of skin aging simultaneously, resolving the contradiction between basic care and anti-aging effectiveness.
Solution Approach 2:
The patent specifies optimized concentration ranges for each active ingredient to maximize anti-aging effects while maintaining skin compatibility. By carefully controlling the parameters of ingredient concentrations and formulation composition, the product achieves reliable reduction of visible aging signs without causing adverse effects, thereby resolving the effectiveness contradiction.
2Reliability
If aggressive anti-aging treatments are applied, then visible signs of aging are reduced, but skin inflammation and irritation may increase
Solution Approach 1:
The patent leverages the anti-inflammatory properties of neolignans to counteract potential irritation from anti-aging ingredients. The formulation converts the potential harm of aggressive treatment into benefit by using the same neolignan compound to simultaneously provide antioxidant protection and reduce inflammation, thereby achieving effective anti-aging without increasing skin irritation.
Solution Approach 2:
The patent optimizes the concentration of active ingredients and incorporates soothing components to maintain skin barrier function. By adjusting formulation parameters to include anti-inflammatory agents at appropriate levels, the product delivers effective anti-aging treatment while preventing inflammation, resolving the contradiction between treatment effectiveness and skin safety.
Data Source
AI summary
Provided are compositions, comprising a neolignan, ectoin, and a molecule of Formula I:wherein R1, R2 and R3 are independently H, methyl, ethyl, propyl, or isopropyl; wherein X is S or O. In some cases, the molecule of Formula I is ergothioneine (EGT). In some cases, the at least one neolignan is honokiol or a derivative thereof. Honokiol may be provided in the form of magnolia bark extract. Methods of making and using these compositions are also provided.